Cargando…
Longitudinal metabolic study of red blood cells from patients undergoing gender-affirming testosterone therapy
Autores principales: | Roy, Micaela Kalani, Wilkerson, Rebecca Burgoyne, Alexander, Keisha, Nokoff, Natalie J., Cree-Green, Melanie, D’Alessandro, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424140/ https://www.ncbi.nlm.nih.gov/pubmed/36001490 http://dx.doi.org/10.1182/bloodadvances.2022008061 |
Ejemplares similares
-
OR13-4 Bone Mineral Density in Transgender Youth on Gender Affirming Therapies
por: Ma, Nina, et al.
Publicado: (2022) -
Angiofibroma stimulation in a transgender person receiving gender-affirming testosterone
por: Bubley, Jeffrey A., et al.
Publicado: (2020) -
Localized Rhabdomyolysis Associated With Testosterone Enanthate for Gender-Affirming Hormonal Therapy
por: Reddy, Rashmi, et al.
Publicado: (2022) -
Two Transgender Men Receiving Subdermal Testosterone Pellets for Gender Affirmation
por: Wolf Pulsiano, Sune L., et al.
Publicado: (2023) -
OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023)